These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 24301753

  • 1. Expression profile analysis reveals putative prostate cancer-related microRNAs.
    Song H, Liu Y, Pan J, Zhao ST.
    Genet Mol Res; 2013 Oct 24; 12(4):4934-43. PubMed ID: 24301753
    [Abstract] [Full Text] [Related]

  • 2. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S.
    Cell Biochem Biophys; 2014 Dec 24; 70(3):1849-58. PubMed ID: 25087086
    [Abstract] [Full Text] [Related]

  • 3. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
    Feng F, Wu J, Gao Z, Yu S, Cui Y.
    Medicine (Baltimore); 2017 Jan 24; 96(1):e5679. PubMed ID: 28072703
    [Abstract] [Full Text] [Related]

  • 4. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C, Chen H, Wang T, Zhang W, Ru G, Lang J.
    Prostate; 2015 Apr 01; 75(5):500-16. PubMed ID: 25597612
    [Abstract] [Full Text] [Related]

  • 5. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J, Zeng Y.
    Eur Rev Med Pharmacol Sci; 2015 Apr 01; 19(5):825-34. PubMed ID: 25807437
    [Abstract] [Full Text] [Related]

  • 6. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 01; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z, Yawei W, Lianna L, Haifeng L, Hui Z.
    Med Sci Monit; 2015 Dec 02; 21():3748-59. PubMed ID: 26628405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.
    Samaan S, Lichner Z, Ding Q, Saleh C, Samuel J, Streutker C, Yousef GM.
    Biol Chem; 2014 Sep 02; 395(9):991-1001. PubMed ID: 25153383
    [Abstract] [Full Text] [Related]

  • 12. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
    Ma D, Zhang YY, Guo YL, Li ZJ, Geng L.
    Chin Med J (Engl); 2012 Dec 02; 125(23):4270-6. PubMed ID: 23217399
    [Abstract] [Full Text] [Related]

  • 13. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.
    Cell Tissue Res; 2013 Jan 02; 351(1):85-98. PubMed ID: 23111773
    [Abstract] [Full Text] [Related]

  • 14. [Expression profiles of microRNAs in radioresistant esophageal cell line].
    Zheng ZF, Su HF, Zou Y, Peng Z, Wu SX.
    Zhonghua Yi Xue Za Zhi; 2011 Mar 08; 91(9):639-42. PubMed ID: 21600139
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H, Wang Y.
    Tumour Biol; 2016 Jan 08; 37(1):1051-9. PubMed ID: 26269115
    [Abstract] [Full Text] [Related]

  • 17. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y, Mei Q.
    Mol Vis; 2015 Jan 08; 21():1307-17. PubMed ID: 26730174
    [Abstract] [Full Text] [Related]

  • 18. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.
    Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sañudo A, Antunes AA, Srougi M.
    Urol Oncol; 2011 Jan 08; 29(3):265-9. PubMed ID: 19372056
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
    Maimaiti A, Abudoukeremu K, Tie L, Pan Y, Li X.
    Gene; 2015 Mar 10; 558(2):271-7. PubMed ID: 25576219
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.